Almokalant

	WikiDoc Resources for Almokalant
Articles
Most recent articles on Almokalant Most cited articles on Almokalant Review articles on Almokalant Articles on Almokalant in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Almokalant Images of Almokalant Photos of Almokalant Podcasts & MP3s on Almokalant Videos on Almokalant
Evidence Based Medicine
Cochrane Collaboration on Almokalant Bandolier on Almokalant TRIP on Almokalant
Clinical Trials
Ongoing Trials on Almokalant at Clinical Trials.gov Trial results on Almokalant Clinical Trials on Almokalant at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Almokalant NICE Guidance on Almokalant NHS PRODIGY Guidance FDA on Almokalant CDC on Almokalant
Books
Books on Almokalant
News
Almokalant in the news Be alerted to news on Almokalant News trends on Almokalant
Commentary
Blogs on Almokalant
Definitions
Definitions of Almokalant
Patient Resources / Community
Patient resources on Almokalant Discussion groups on Almokalant Patient Handouts on Almokalant Directions to Hospitals Treating Almokalant Risk calculators and risk factors for Almokalant
Healthcare Provider Resources
Symptoms of Almokalant Causes & Risk Factors for Almokalant Diagnostic studies for Almokalant Treatment of Almokalant
Continuing Medical Education (CME)
CME Programs on Almokalant
International
Almokalant en Espanol Almokalant en Francais
Business
Almokalant in the Marketplace Patents on Almokalant
Experimental / Informatics
List of terms related to Almokalant

Almokalant
	File:Almokalant.svg
Gene therapy
Clinical data
ATC code	None;
Physiological data
Legal status
Pharmacokinetic data
Identifiers
	IUPAC name 4-(3-{Ethyl[3-(propane-1-sulfinyl)propyl]amino}-2-hydroxypropoxy)benzonitrile;
CAS Number	123955-10-2;
PubChem Template:Abbreviation	3033962;
ChemSpider	2298526 ;
UNII	I9NG89L275;
ChEMBL	ChEMBL362103 ;
Chemical and physical data
Formula	C18H28N2O3S
Molar mass	352.5 g/mol
3D model (JSmol)	Interactive image;
	SMILES O=S(CCC)CCCN(CC)CC(O)COc1ccc(C#N)cc1;
	InChI InChI=1S/C18H28N2O3S/c1-3-11-24(22)12-5-10-20(4-2)14-17(21)15-23-18-8-6-16(13-19)7-9-18/h6-9,17,21H,3-5,10-12,14-15H2,1-2H3 ; Key:ZMHOBBKJBYLXFR-UHFFFAOYSA-N ;
	(verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Almokalant is drug used to treat arrhythmia.^[1] It is a potassium channel blocker. It has been found to have teratogenic effects in rats.^[2]

↑ Wiesfeld A C; Crijns H J; Bergstrand R H; Almgren O; Hillege H L; Lie K I (1993). "Torsades de pointes with Almokalant, a new class III antiarrhythmic drug". American heart journal. 126 (4): 1008–1011.
↑ Signs of Almokalant - Teratogenic Agent, wrongdiagnosis.com